NVS: Novartis AG Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NVS: Novartis AG

NVS 139.18

+0.2%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Doc Bones	6/13/2007 10:10:39 AM
	of 116

Novartis Gets EU OK for New Flu Vaccine Wednesday June 13, 8:43 am ET Novartis Receives European Union Approval for Its New Flu Vaccine Optaflu BASEL, Switzerland (AP) -- Novartis AG has received European Union approval for flu vaccine Optaflu, the Swiss drugmaker said Wednesday. Iceland and Norway also have approved Optaflu for use in vaccination against seasonal influenza, Novartis said, adding that its use of proprietary cell culture technology could help in the event of a flu pandemic. "Optaflu marks the first major innovation in influenza vaccine manufacturing in over 50 years," said Dr. Joerg Reinhardt, chief executive of Novartis vaccines and diagnostics. Reinhardt said the vaccine would provide a "more flexible and reliable production process," helping to meet demand for seasonal flu treatments and vaccines in case of a pandemic. Health officials around the world have been preparing in case the bird flu virus that has killed at least 190 people since it began ravaging Asian poultry stocks in 2003 mutates into a form that spreads among humans. The World Health Organization has warned that a pandemic could kill hundreds of thousands around the globe. Novartis said Optaflu is expected to be available in Germany and Austria for next winter's flu season. It will be available in the other 25 EU countries by the 2008-2009 season. The company said it will likely seek U.S. regulatory approval next year. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next